Furthermore, it has been reported that PRMT5 and MEP50 expression is upregulated in various cancers, and the cytoplasmic localisation of PRMT5/MEP50 is associated with a wide variety of cellular processes, including signal transduction pathways that are highly relevant to the pathogenesis of cancer [21,22,23]. This evidence concerns the gene PRMT5 and cancer.